Literature DB >> 21245364

Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.

David Verhaert1, Kathryn Richards, Jill A Rafael-Fortney, Subha V Raman.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21245364      PMCID： PMC3057042          DOI： 10.1161/CIRCIMAGING.110.960740

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  78 in total

1.  Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series.

Authors:  A E Buckley; J Dean; I R Mahy
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

2.  Cardioprotection for Duchenne's muscular dystrophy.

Authors:  Y Ishikawa; J R Bach; R Minami
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

3.  Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI.

Authors:  Ali Yilmaz; Hans-Jürgen Gdynia; Albert C Ludolph; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  Circulation       Date:  2010-03-16       Impact factor: 29.690

4.  Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study.

Authors:  Gillian C Smith; Maria Kinali; Sanjay K Prasad; Gisèle Bonne; Francesco Muntoni; Dudley J Pennell; Petros Nihoyannopoulos
Journal:  J Cardiovasc Magn Reson       Date:  2006       Impact factor: 5.364

5.  A missense mutation in the exon 8 of lamin A/C gene in a Japanese case of autosomal dominant limb-girdle muscular dystrophy and cardiac conduction block.

Authors:  T Kitaguchi; S Matsubara; M Sato; K Miyamoto; S Hirai; K Schwartz; G Bonne
Journal:  Neuromuscul Disord       Date:  2001-09       Impact factor: 4.296

Review 6.  The muscular dystrophies.

Authors:  Alan E H Emery
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

7.  Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I.

Authors:  Deepak Bhakta; Miriam R Lowe; William J Groh
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

8.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.

Authors:  Kan N Hor; Janaka Wansapura; Larry W Markham; Wojciech Mazur; Linda H Cripe; Robert Fleck; D Woodrow Benson; William M Gottliebson
Journal:  J Am Coll Cardiol       Date:  2009-04-07       Impact factor: 24.094

9.  Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice.

Authors:  A Franco-Obregón; J B Lansman
Journal:  J Physiol       Date:  1994-12-01       Impact factor: 5.182

10.  Mechanical function of dystrophin in muscle cells.

Authors:  C Pasternak; S Wong; E L Elson
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539
View more
  61 in total

Review 1.  Transverse tubule remodelling: a cellular pathology driven by both sides of the plasmalemma?

Authors:  David J Crossman; Isuru D Jayasinghe; Christian Soeller
Journal:  Biophys Rev       Date:  2017-07-10

2.  Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.

Authors:  Sean M Lang; Svetlana Shugh; Wojciech Mazur; Joshua J Sticka; Mantosh S Rattan; John L Jefferies; Michael D Taylor
Journal:  Pediatr Cardiol       Date:  2015-05-16       Impact factor: 1.655

Review 3.  Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines.

Authors:  Marcelo S Nacif; Andrew E Arai; Joao A C Lima; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-29       Impact factor: 5.364

Review 4.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

5.  Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.

Authors:  Gianna Móes Albuquerque-Pontes; Heliodora Leão Casalechi; Shaiane Silva Tomazoni; Andrey Jorge Serra; Cheila de Sousa Bacelar Ferreira; Rodrigo Barbosa de Oliveira Brito; Brunno Lemes de Melo; Adriane Aver Vanin; Kadma Karênina Damasceno Soares Monteiro; Humberto Dellê; Lucio Frigo; Rodrigo Labat Marcos; Paulo de Tarso Camillo de Carvalho; Ernesto Cesar Pinto Leal-Junior
Journal:  Lasers Med Sci       Date:  2017-12-05       Impact factor: 3.161

Review 6.  The role of βII spectrin in cardiac health and disease.

Authors:  Mohamed H Derbala; Aaron S Guo; Peter J Mohler; Sakima A Smith
Journal:  Life Sci       Date:  2017-11-09       Impact factor: 5.037

Review 7.  Dilated cardiomyopathy.

Authors:  Neal K Lakdawala; Jeffery R Winterfield; Birgit H Funke
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-09-28

8.  Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle.

Authors:  Mattia Quattrocelli; Melissa Swinnen; Giorgia Giacomazzi; Jordi Camps; Ines Barthélemy; Gabriele Ceccarelli; Ellen Caluwé; Hanne Grosemans; Lieven Thorrez; Gloria Pelizzo; Manja Muijtjens; Catherine M Verfaillie; Stephane Blot; Stefan Janssens; Maurilio Sampaolesi
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

9.  Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.

Authors:  Dawn A Delfín; Kara E Zang; Kevin E Schill; Nikita T Patel; Paul M L Janssen; Subha V Raman; Jill A Rafael-Fortney
Journal:  Neuromuscul Disord       Date:  2012-06-29       Impact factor: 4.296

Review 10.  Myotonic Dystrophy Type 1 Management and Therapeutics.

Authors:  Cheryl A Smith; Laurie Gutmann
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.